ReportsandReports - Immunosuppressants, Organ Transplants, and the Potential of Regenerative Medicine: Market Size, Competitive Landscape, and Pipeline Analysis
The development of novel immunosuppressants, coupled with advances in immunology, surgical techniques, donor selection and postoperative care have all contributed to improved outcomes for solid organ transplants, which is now established treatment for organ failure of the kidney, pancreas, liver, heart or lung. While modern immunosuppressive regimes have led to important improvements in short-term graft survival rates, these have not been accompanied by a proportionate increase in long-term graft survival.
View full press release